Health
Sinopharm vaccine for COVID-19 elicits immunity to South Africa variant, but with minor effect – Explica
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus…
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus first found in South Africa, but its effect appeared to be weaker, a study showed laboratory with small samples.
Variants of the virus have raised concerns that they may weaken the effects of vaccines and treatments developed before their emergence.
Twelve serum samples taken from recipients of two vaccines developed by a Sinopharm subsidiary…
-
Business24 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General24 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General8 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General23 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting